PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

March 31, 2016

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

SAPIEN XT™ Transapical aortic valve replacement

Transcatheter aortic valve implantation via the transapical approach

Trial Locations (20)

1019

Medizinische Universitat Wien Univ.Klinik f.Chirurgie, Vienna

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

29549

Herz-Und Gefasszentrum Bad Bevensen, Bad Bevensen

32545

Herz-und Diabeteszentrum NRW, Bad Oeynhausen

45122

University Hospital Essen, West German Heart Center, Essen

49214

Schüchtermann-Klinik, Bad Rothenfelde

50924

Heart Center University Cologne, Cologne

61231

Kerckhoff-Klinik, Bad Nauheim

70376

Robert-Bosch-Krankenhaus, Stuttgart

75018

Hôspital Bichat, Paris

76185

Cardiac Surgery Karlsruhe, Karlsruhe

80636

German Heart Center Munich, Munich

81377

University Hospital Munich-Grosshadern, Munich

81925

Hospital Munich-Bogenhausen, Munich

91054

University Clinic Erlangen, Erlangen

97616

Herz-und-Gefass Klinik, Bad Neustadt an der Saale

01307

Herzzentrum Dresden GmbH, Dresden

04829

Heart Center Leipzig, Leipzig

SE1 7EH

St. Thomas' Hospital - NHS Trust, London

SE5 9RS

King's College Hospital, London

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY